CD4+ cell count and risk for antiretroviral drug resistance among women using peripartum nevirapine for perinatal HIV prevention.pdf

Embed Size (px)

Citation preview

  • 8/11/2019 CD4+ cell count and risk for antiretroviral drug resistance among women using peripartum nevirapine for perinata

    1/5

  • 8/11/2019 CD4+ cell count and risk for antiretroviral drug resistance among women using peripartum nevirapine for perinata

    2/5

  • 8/11/2019 CD4+ cell count and risk for antiretroviral drug resistance among women using peripartum nevirapine for perinata

    3/5

  • 8/11/2019 CD4+ cell count and risk for antiretroviral drug resistance among women using peripartum nevirapine for perinata

    4/5

  • 8/11/2019 CD4+ cell count and risk for antiretroviral drug resistance among women using peripartum nevirapine for perinata

    5/5